Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2

Conditions

Lymphoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Leukemia 4Recurrence 3Multiple Myeloma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Burkitt Lymphoma 3Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphohistiocytosis, Hemophagocytic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoblastic Lymphadenopathy 2Hodgkin Disease 2Epstein-Barr Virus Infections 2Dendritic Cell Sarcoma, Interdigitating 2Unspecified Childhood Solid Tumor, Protocol Specific 1Sezary Syndrome 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pneumonia, Pneumocystis 1Pneumonia 1Neuroma 1

Interventions

spartalizumab 2pegaspargase 2Methylprednisolone 2Etoposide 2Dexamethasone 2toripalimab 1ruxolitinib 1Valproic Acid 1Valganciclovir 1Rituximab 1Liquid Biopsy 1Lenalidomide 1Gemcitabine 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Epstein-Barr Virus Infections × Methylprednisolone × Clear all
NCT02912702 2016-09-23

L-DEP as an Initial Treatment for EBV-HLH

Beijing Friendship Hospital

Phase 3 Unknown
120 enrolled
Myeloid

Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

NCT02631109 2016-08-04

L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis

Beijing Friendship Hospital

Phase 3 Unknown
120 enrolled
Myeloid

Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡